Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85,639 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New clinical screening strategy to distinguish HNF1A variant-induced diabetes from young early-onset type 2 diabetes in a Chinese population.
Ma Y, Gong S, Wang X, Cai X, Xiao X, Gu W, Yang J, Zhong L, Xiao J, Li M, Liu W, Zhang S, Zhou X, Li Y, Zhou L, Zhu Y, Luo Y, Ren Q, Huang X, Gao X, Zhang X, Zhang R, Chen L, Wang F, Wang Q, Hu M, Han X, Ji L. Ma Y, et al. Among authors: yang j. BMJ Open Diabetes Res Care. 2020 Mar;8(1):e000745. doi: 10.1136/bmjdrc-2019-000745. BMJ Open Diabetes Res Care. 2020. PMID: 32238361 Free PMC article.
Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
Luo Y, Paul SK, Zhou X, Chang C, Chen W, Guo X, Yang J, Ji L, Wang H. Luo Y, et al. Among authors: yang j. J Diabetes Res. 2017;2017:7602408. doi: 10.1155/2017/7602408. Epub 2017 Jan 12. J Diabetes Res. 2017. PMID: 28168204 Free PMC article. Clinical Trial.
Polyethylene glycol loxenatide injections added to metformin effectively improve glycemic control and exhibit favorable safety in type 2 diabetic patients.
Chen X, Lv X, Yang G, Lu D, Piao C, Zhang X, Jiang H, Xie Y, Yang J, Li X, Li Y, Xiao X, Li Y, Sun L, Zheng S, Cheng Q, Peng Y, Yang W. Chen X, et al. Among authors: yang g, yang w, yang j. J Diabetes. 2017 Feb;9(2):158-167. doi: 10.1111/1753-0407.12397. Epub 2016 Jun 21. J Diabetes. 2017. PMID: 26989888 Clinical Trial.
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
Ji L, Du Y, Xu M, Zhou X, Mo Z, Ma J, Li J, Li Y, Lin J, Wang Y, Yang J, Song W, Jin H, Pang S, Liu H, Li P, Liu J, Yao M, Li W, Jiang X, Shen F, Geng H, Zhou H, Ran J, Lei M, Du Y, Ye S, Guan Q, Lv W, Tan H, Chen T, Yang J, Qin G, Li S, Chen L. Ji L, et al. Among authors: yang j. Diabetologia. 2021 May;64(5):1066-1078. doi: 10.1007/s00125-021-05392-9. Epub 2021 Mar 9. Diabetologia. 2021. PMID: 33687487 Free PMC article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
Ji L, Du Y, Xu M, Zhou X, Mo Z, Ma J, Li J, Li Y, Lin J, Wang Y, Yang J, Song W, Jin H, Pang S, Liu H, Li P, Liu J, Yao M, Li W, Jiang X, Shen F, Geng H, Zhou H, Ran J, Lei M, Du Y, Ye S, Guan Q, Lv W, Tan H, Chen T, Yang J, Qin G, Li S, Chen L. Ji L, et al. Among authors: yang j. Diabetologia. 2021 Aug;64(8):1900-1901. doi: 10.1007/s00125-021-05460-0. Diabetologia. 2021. PMID: 34037812 Free PMC article. No abstract available.
[Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China].
Pan C, Li W, Zeng J, Li C, Yang J, Ji Q, Lu J, Lyu X, Li X, Qu S, Xu X, Xue Y, Li L, Jiang Z, Zheng B, Bu R, Han P, Liu Y, Liu J, Peng Y, Liu X, Liu Z, Yan L, Lei M, Li X, Song Q, Shi B, Gu W, Li Z. Pan C, et al. Among authors: yang j. Zhonghua Nei Ke Za Zhi. 2015 Nov;54(11):949-53. Zhonghua Nei Ke Za Zhi. 2015. PMID: 26759214 Clinical Trial. Chinese.
85,639 results
You have reached the last available page of results. Please see the User Guide for more information.